Dashboard
Manage Tickers

SLSN NANOPHASE TECHNOLOGIES Corp

OTC nanophase.com


$ 3.34 $ -0.23 (-6.55 %)    

Thursday, 30-Oct-2025 15:59:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 633.20 $ -9.72 (-1.53 %)
DIA $ 475.83 $ -1.36 (-0.29 %)
SPY $ 684.43 nm (nm)
TLT $ 90.42 nm (nm)
GLD $ 371.67 $ 7.13 (1.96 %)
$ 3.28
$ 3.50
$ 3.00 x 300
$ 3.80 x 727
-- - --
$ 1.34 - $ 16.56
29,853
na
238.06M
$ 1.07
$ 45.49
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-16-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-26-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-04-2019 12-31-2018 10-K
28 11-19-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-30-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-12-2017 03-31-2017 10-Q
35 03-29-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-12-2016 06-30-2016 10-Q
38 05-13-2016 03-31-2016 10-Q
39 03-29-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Solésence Appoints Kevin Cureton As Presid...
09/03/2025 12:04:22

Core News & Articles
Solesence Q2 EPS $0.04, Sales $20.26M
07/31/2025 20:04:54

Solesence (NASDAQ:SLSN) reported quarterly earnings of $0.04 per share. The company reported $20.26 million in sales this quar...

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

Core News & Articles
Solésence To Join Russell 3000 And Russell...
06/24/2025 12:14:07

Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categorie...

Core News & Articles
Solésence Entered Into Amendments To Its E...
06/02/2025 10:17:34

The new facility expands the Company's three loan agreements to a maximum borrowing capacity from $14.2 million to $23.0 mi...

Core News & Articles
Solesence Q1 EPS $0.00 Down From $0.02 YoY...
05/05/2025 20:34:40

Solesence (NASDAQ:SLSN) reported $14.63 million in sales this quarter. This is a 48.21 percent increase over sales of $9.87 mil...

Core News & Articles
Solésence Announces Uplisting To Nasdaq
04/07/2025 20:11:07

ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION